If you liked this article you might like

Allergan's Healthy Prospects
Cramer's 6 Stocks in 60 Seconds: SNV TXN UL CREE MAPP KBH (Update 1)
2013 FDA Drug Approval Decision Calendar
Biotech Stock Mailbag: Aveo, Anthera, Amarin, MAP Pharma